Login / Signup

Appropriate timing to start and optimal response evaluation of high-dose corticosteroid therapy for patients with acute liver failure.

Keisuke KakisakaKojiro KataokaYuji SuzukiHidekatsu KurodaYasuhiro Takikawa
Published in: Journal of gastroenterology (2017)
We propose the appropriate timing to start high-dose corticosteroid therapy in patients with ALI/ALF; 40% of JHEPM probability, 1.53 of PT-INR, and 52% of PT because these values were theoretically discriminated at 98% coverage to the patients with coma. Because the study contained selection bias, the appropriate timing for therapy should be confirmed in a future prospective study.
Keyphrases
  • high dose
  • liver failure
  • low dose
  • stem cell transplantation
  • hepatitis b virus
  • healthcare
  • current status
  • mesenchymal stem cells
  • replacement therapy